Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.95p
   
  • Change Today:
      0.000p
  • 52 Week High: 7.10
  • 52 Week Low: 2.85
  • Currency: UK Pounds
  • Shares Issued: 274.89m
  • Volume: 112,406
  • Market Cap: £10.86m
  • RiskGrade: 304

Evgen Pharma Overview

Evgen is a clinical stage drug development company focused on the development of sulforaphane-based compounds, a new class of pharmaceuticals which are synthesised in a proprietary, well-tolerated, stable formulation.

Key Personnel

CEO: Huw Jones
CFO: Richard Moulson
Independent Non-Executive Director: Susan Clement-Davies
Independent Non-Executive Director: Alan Barge
Non-Executive Chairman: Barry Clare
Senior Independent Director: Susan (Sue) Foden
Non-Executive Dir:

Contact Details

Address: Liverpool Science Park Innovation Centre 2, 146 Brownlow Hill, Liverpool, Merseyside, United Kingdom , L3 5RF
Website: http://www.evgen.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BSVYN304

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Evgen Pharma Market Data

Currency UK Pounds
Share Price 3.95p
Change Today 0.000p
% Change 0.00 %
52 Week High 7.10
52 Week Low 2.85
Volume 112,406
Shares Issued 274.89m
Market Cap £10.86m
RiskGrade 304

Evgen Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.82% below the market average15.82% below the market average15.82% below the market average15.82% below the market average15.82% below the market average
53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average
Price Trend
36.74% below the market average36.74% below the market average36.74% below the market average36.74% below the market average36.74% below the market average
14.75% below the sector average14.75% below the sector average14.75% below the sector average14.75% below the sector average14.75% below the sector average
Income Not Available
Growth Not Available

Evgen Pharma Dividends

No dividends found

Trades for 02-Jun-2023

Time Volume / Share Price
12:46 87,507 @ 3.98p
08:02 24,899 @ 3.98p

Evgen Pharma Key Personnel

CFO Richard Moulson
CEO Huw Jones

Top of Page